Clinical Trial Update: PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing pharmacokinetics of melphalan during treatment with melflufen and dexamethasone in patients with relapsed/refractory multiple m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melflufen (melphalan flufenamide)

Snippet

Sponsor: Oncopeptides AB | Conditions: Renal Impairment, Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2023-03-09